I ran into a MSB die hard the other day that assured me that MSB will blow PAR out of the water. Sticking to facts I knew about PAR gave my point of view, but did not know much about MSB so was careful. Less carefel than they were.
After further research I can see MSB also 'had' a PR connection before he moved on, and were looking in the OA space, but seem to be now going in a slightly different direction and I'm not convinced that they are competition to PAR ( I know you weren't suggesting that, but I was wondering it) . The look to have an interesting history, a lot of promise and then the wheels fell off. Looks like they might be getting the train back on the tracks and I'm certainly looking more into them. But I'm ready for round two of the conversation for PAR v MSB and I'm still seeing PAR as the OA drug of choice
PAR Price at posting:
$1.37 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)